Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE ( © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 January 2020

Abstract and Keywords

Severe psychiatric disorders may be resistant to conventional pharmacological and psychotherapeutic treatments. Invasive interventions such as deep-brain stimulation (DBS) and neurosurgical ablation (lesioning) can modulate dysfunctional neural circuits implicated in these disorders. Yet these two forms of psychiatric neurosurgery are still experimental and investigational and thus their safety and efficacy have yet to be established. This chapter is an examination and discussion of the main ethical issues surrounding the experimental use of DBS and lesioning for treatment-refractory psychiatric disorders. I address questions regarding research subjects’ exposure to risk and informed consent to be enrolled in clinical trials testing these techniques for major depression and obsessive-compulsive disorder. These questions include whether or to what extent the therapeutic misconception influences decisions to enroll in these trials. I then explore similar questions about the use of DBS for schizophrenia and anorexia nervosa. Finally, I discuss the obligations of researchers conducting these studies to research subjects.

Keywords: Consent, deep brain stimulation, lesioning, risk, psychiatric disorders, research, Therapeutic Misconception

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.